Theraclion SA Logo

Theraclion SA

ISIN

FR0010120402

Ticker

ALTHE

Sector

Health Care

Sub-Industry

Health Care Equipment

Country

France

Year Founded

2004

About Theraclion SA

Company Description

At Theraclion we believe that surgery, as we know it, is outdated. It converts optimistic patients into anxious individuals, brilliant doctors into exhausted system executors and stretches healthcare systems to the limit. We have disrupted this convention by creating extracorporeal treatment platforms.

We replace surgery with a robotic treatment from outside the body using High Intensity Focussed Ultrasound (HIFU). Our leading edge echotherapy platforms are currently CE marked in non-invasive treatment of varicose veins with SONOVEIN® and of breast fibroadenomas and thyroid nodules with Echopulse®. Located in Malakoff, near Paris, our employees live and breath innovation by extensive clinical research and harness artificial intelligence to reshape surgery by making non-invasive echotherapy the new standard. Located in Malakoff, near Paris, Theraclion brings together a team of 25 people, more than half of whom are dedicated to R&D and clinical trials.

Served Area

Worldwide

Headquarters

102 Rue Etienne Dolet
92240, Malakoff
France

Insider Trades

Date Trading entity / Person Association Trade type Volume
10.06.2024 None Other Other EUR 48.80
26.01.2024 None Other Buy EUR 32,839.33
21.12.2023 None Other Buy EUR 0.00
15.11.2023 None Other Buy EUR 0.00
01.07.2022 None Other Other EUR 107,999.38

Capital Markets Information

ISIN

FR0010120402

LEI

9695007X7HA7A1GYD29

Listed Stock Exchange

Euronext Paris

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.